Evidence-Based Persuasion: An Ethical Imperative
David Shaw, Bernice Elger. JAMA. Published online April 08, 2013. http://jama.jamanetwork.com/article.aspx?articleid=1676494
Leggi
Online Medical Professionalism: Patient and Public Relationships: Policy Statement From the American College of Physicians and the Federation of State Medical Boards
Jeanne M. Farnan, Lois Snyder Sulmasy, Brooke K. Worster, et al. Annals of Internal Medicine. 11 april 2013 http://annals.org/article.aspx?articleid=1675927
Leggi
Personalized Medicine vs Guideline-Based Medicine
Goldberger JJ, Buxton AE. JAMA. 2013;():1-2. - Published online May 27, 2013 http://jama.jamanetwork.com/article.aspx?articleid=1691756
Leggi
Why we can’t trust clinical guidelines
Jeanne Lenzer BMJ 2013;346:f3830 http://www.bmj.com/content/346/bmj.f3830?etoc=
Leggi
Restoring the integrity of the clinical trial evidence base
Elizabeth Loder, Fiona Godlee, Virginia Barbour, Margaret Winker, VB and MW: on behalf of the PLOS Medicine editors BMJ 2013;346:f3601 http://www.bmj.com/content/346/bmj.f3601
Leggi
Searching for unpublished data for Cochrane reviews: cross sectional study
Jeppe Bennekou Schroll, Lisa Bero, Peter C Gøtzsche BMJ 2013;346:f2231 http://www.bmj.com/content/346/bmj.f2231
Leggi
Restoring invisible and abandoned trials: a call for people to publish the findings
Peter Doshi, Kay Dickersin, David Healy, S Swaroop Vedula, Tom Jefferson BMJ 2013;346:f2865 http://www.bmj.com/content/346/bmj.f2865
Leggi
Interpreting Adverse Signals in Diabetes Drug Development Programs
Clifford J. Bailey Diabetes Care July 2013 36:2098-2106; published ahead of print May 21, 2013 http://care.diabetesjournals.org/content/36/7/2098.abstract.html
Leggi
Assessing the Benefit-Risk for New Drugs: Are the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee and the Division of Metabolism and Endocrinology Products in sync? (Commentary)
Eric P. Brass Diabetes Care July 2013 36:1823-1826; published ahead of print May 21, 2013 http://care.diabetesjournals.org/content/36/7/1823.extract?sid=5b4d2f92-a974-4cf4-8e5f-ad71edc8b208
Leggi
Signals and Noise in Drug Safety Analyses: The incretin therapy debate provides the rationale for revamping epidemiologic pharmacovigilance (Editorial)
William T. Cefalu, Julio Rosenstock, Robert R. Henry, and Matthew Riddle Diabetes Care July 2013 36:1804-1806; published ahead of print May 21, 2013 http://care.diabetesjournals.org/content/36/7/1804.extract.html
Leggi